Georgetown University is an internationally recognized educational and research university engaged in the discovery and development of new cancer diagnostics and therapeutics through the programs of the Lombardi Comprehensive Cancer Center. Shuttle Pharmaceuticals subcontracted clinical aspects of SBIR funded research to establish cancer cell lines from African-Americans patients and to develop predictive biomarkers for patient sensitivity to radiation late-effects.
George Washington Cancer Center
The Small Business Innovation Research program is a United States Government program, managed by the Small Business Administration and intended to help small businesses conduct research and development of products that offer potential for commercialization. Funding to Shuttle Pharmaceuticals has been in the form of contracts for projects that meet U.S. government R&D needs.